Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2013
Price : $35 *
At a glance
- Drugs Anti-infectives (Primary) ; Ceftaroline fosamil (Primary)
- Indications Gram-negative infections; Gram-positive infections
- Focus Therapeutic Use
- Acronyms CERBERUS
- Sponsors AstraZeneca
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Oct 2012 New trial record
- 01 Oct 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.